Patent · US Active

Human antibodies against rabies and uses thereof

US8226952B2 · kind B2 · utility

6Cited by

2References

23Claims

0Family size

Assignees

University of Massachusetts · US
Centers for Disease Control and Prevention · US

Inventors

William D. Thomas · San Jose, US
Donna M. Ambrosino · Brookline, US
Robert Mandell · Moraga, US
Susan Sloan · Newton, US
Gregory Babcock · Marlborough, US
Charles Rupprecht · Lawrenceville, US

Key dates

Filing date	Apr 26, 2010
Grant date	Jul 24, 2012
Priority date	—
Expiry date	Apr 26, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/20234
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Human monoclonal antibodies that specifically bind to rabies virus, antigen binding portions thereof, and methods of making and using such antibodies and antigen binding portions thereof for treating rabies virus in a subject, are provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.